Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

391.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 445.00
  • 52 Week Low: 167.20
  • Currency: UK Pounds
  • Shares Issued: 105.96m
  • Volume: 73,438
  • Market Cap: £414.31m
  • RiskGrade: 125
  • Beta: 0.03

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -205.7% -30.1%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 4.6 3.4
Pr/Book 5.3  
Latest F'cast
Revenue -36.0% 44.5%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OXB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 64.06 (20.89) (22.10)p n/a n/a n/a n/a 0.0%
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 129.36 (38.88) (41.07)p n/a n/a n/a n/a 0.0%
31-Dec-25 167.21 (16.34) (26.55)p n/a n/a n/a n/a 0.0%
31-Dec-26 211.80 7.62 (9.54)p n/a n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

OXB Company Announcements

Block Listing Return 02-Jan-2025 07:00 RNS
Total Voting Rights 02-Jan-2025 07:00 RNS
Total Voting Rights 02-Dec-2024 07:00 RNS

Latest OXB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 391.00p
Change Today -1.00p
% Change -0.26 %
52 Week High 445.00
52 Week Low 167.20
Volume 73,438
Shares Issued 105.96m
Market Cap £414.31m
Beta 0.03
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.28% below the market average31.28% below the market average31.28% below the market average31.28% below the market average31.28% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Price Trend
68.62% above the market average68.62% above the market average68.62% above the market average68.62% above the market average68.62% above the market average
75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average
Income Not Available
Growth
52.56% below the market average52.56% below the market average52.56% below the market average52.56% below the market average52.56% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

What The Brokers Say

Strong Buy 2
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 15-Jan-2025

Time Volume / Share Price
14:39 150 @ 390.74p
14:35 1 @ 390.50p
14:35 43 @ 391.50p
14:33 100 @ 391.00p
14:33 47 @ 391.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page